Regional riddle emerges from epilepsy drug studyNew treatment is effective in Canada and U.S., but not in rest of North America; epilepsy classification may have been a factor Canadian MS clinics see results with natalizumabReal-world outcomes with investigational drug still favourable Train the brain to ward off dementia Course improves memory by recruiting healthy tissue Device uses submarine technology to diagnose stroke quickly Prototype is portable, easy to use Evidence lacking for Alzheimer’s drug in mild cases Sunlight, vitamin D linked to lower MS risk Research from Australia—which has the highest skin cancer rate in the world—suggests sun exposure also can be viewed in a sort of positive light: It may reduce the risk for developing multiple sclerosis. A window into the body Gilenya: new MS drug approved by Health Canada Health Canada approves first disease-modifying oral treatment for multiple sclerosis in Canada. Brain scans reveal secrets of acupuncture’s success Technique blocks pain signals and reduces expectations of pain, MRI shows MRS detects athletes’ concussion damage Researcher hopes technique allows for ‘in-life diagnosis’ First Previous 49 50 51 52 53 Next Last
